OSX.ASX: Further Drawdown of T1 of the Redeemable Convertible Notes

Further Drawdown of T1 of the Redeemable Convertible Notes

Stock	Osteopore Ltd (OSX.ASX)
Release Time	7 Apr 2025, 4:27 p.m.
Price Sensitive	Yes

This feature provides summaries of price-sensitive announcements for companies followed by users on InvestorPA. The summaries are generated by large language models so please interpret with care.

Osteopore Draws Down Further Tranche 1 Funds

Key Points

Osteopore draws down additional A$1 million from Tranche 1 of redeemable convertible notes
Funds to be used for ordinary business operations and future developments
Subscription agreement with Advance Opportunities Fund and Advance Opportunities Fund I

Full Summary

Osteopore Limited, a global leader in 3D-printed biomimetic and bioresorbable implants, has announced that it has drawn down a further A$1 million from Tranche 1 of the redeemable convertible notes it entered into with Advance Opportunities Fund and Advance Opportunities Fund I. This follows the initial drawdown of A$2 million from Tranche 1 that was announced on 14 February 2025. The total amount raised from Tranche 1 now stands at A$3 million, with the funds to be used for the company's ordinary business operations and future developments, projects, and investments as opportunities arise. Osteopore's regenerative medicine products, which utilize 3D-printed biomimetic and bioresorbable materials, are designed to stimulate natural bone healing and reduce post-surgery complications associated with permanent bone implants.